everyone. XXXX our and quarter Welcome good quarter fiscal no third exception. year was this and Jen, historically our Thanks, earnings morning, March The quarter call. to is weakest
timing new fell were While variance and challenging of the our route-based revenue EPA the expected costs expansion in business portion to our orders required in the standard we generated. result higher of revenue costs related as than country of short internal adverse markets. additionally sales the testing, of earnings, expectations of costs which healthcare were revenue breakeven in including the the impact a and the higher sales associated Southeast about with lower $XX were in million or of our and higher quarter Exacerbating of home MedSafe recognition
with as of operating growth So following by and two million. to quarters characterized earnings $X.X fiscal moderated compared at prior in consolidated essentially year a XXXX our to third consecutive flat revenue growth start revenue quarter strong the increased year the
of showed Living X% growth Our billings saw a Assisted Healthcare decrease or a quarter decreases manufacture We quarter. of net slight retail in XX% $XXX,XXX third the $X.XX net was professional billings, for million per in and of in to but XXXX. pharmaceutical the third fiscal share loss and the respectively, Home XX% offset the $X.XX increases by loss a in and $X.X or share compared year of quarter
and they look While the the March expectations honestly periods our we at were more disappointing to quarterly assess annual results below are business.
So the with fiscal I million we're be is on and which revenue. estimates the more of in working June will a – year touch $XX.X XX, ended annual ending hope to year line
is potentially shortfall the in professional with sales, MedSafe flu to which about and increased market goal shot March June make the higher Our up additional related the quarter. in growth orders is $XXX,XXX driving
remain our Now move the XXXX solution as offerings. year of increasing through recognition marketplace we focused three we on fiscal primary
about seeing increase X% and more representing double mailback, generated of from we're based our and We're pleased solutions. revenue evidenced is route-based than this the million revenue with XX% by the in as acquired revenue the of XX% the saw about route-based a the company. $X.X the XX-month medication $X.X and growth waste associated traction the medical with of business traditional pick-up, total route-based mailbacks trailing in in our management the Our We [indiscernible] now is the during of million. and business revenue unused business quarter route-based business
predictable generators presence to such to our additional mailback cons as centers quantity other ago stream. years route-based made consolidated As expand establish decision we revenue customers and many surgery more a offering, medium of you know, the a compliment few a address and
Our compares XX, about currently XXXX small-to-medium reaching serviced XXXX. to the customers to of we advantage in the attracting was combination customer acquired March in We of a XX,XXX a offering XX, customers. the as of that two the And offering. as choose directly locations generator comparison XX This our XX,XXX it XXXX found states, and of locations March route-based solution at ability the offerings to service or route-based capacity is or XX% population. we with available the in average mailback targeted competitive quantity our route-based
unused MedSafe XX,XXX to so Now over year. inner a about compares than the we've the X,XXX as about ago, leader installed on which XX,XXX in liners more the liners doubled in liners date. units medication, processed year the collection We've industry to we a
ago collection million receptacles late million year the sold a and X.X were X.X installed changed since two the envelopes. We've ago. their XXXX of XXXX TakeAway and in XXX XXXX sold envelopes years DEA since we've TakeAway rules Our
grow. to market profits the through So the unused to for medications continues flow
of retailers, to drug abuse accidental epidemic the the address across work prescription occurring As providers U.S. communities, growing healthcare poisonings and
the role a We our substances making part with the available by proper effective cost of the treatment and fight combined continued and important have opioid assisting readily effort are disposal growing crisis and in an consumers playing to country. controlled education to solutions the across national
because launch unused be XXXX. more of in to current ongoing down unused up specific this installed of major units greater quarter billings during units calendar be XX% were will segment a a retail were the over a year-to-date, of While prior year. higher the distributed program calendar of the third number in third in of of of XXXX and for XXXX related in our business X% this installs year the they is than sequentially installed with medication rollout than largely But XXXX of included the number quarter quarter quarter MedSafe a the with large to pharmacy. program up billings medications were The
and will a percentage confident are total business medications the unused of We continue larger line increase the become and this believe the and of of growth solutions revenue.
Sales. or of focus Company a of sales existing the and industry. the exceeding budgets, sales the opportunities, President territory Linda sales related meeting growing development, the sales managing leading closing a the March Linda with national healthcare and while Brock Linda including managers the During field account in managers seasoned team, is business quarter as Vice experience accelerating and on extensive leader services is with pipeline. sales joined
on? what portfolio she is selling, So focused offerings, customers, all will solutions, on focus She all our markets. all
she in we sales including where have time base, usage of that had on existing more the regulatory make process. the thing will products New be existing also Salesforce. and deploying she is going spending in of business showed business is doing she customer already cross found we Also going compliance forward. sales The to earlier dedicated focus to that channel we're new our going part resources, We've the expansion successful back opportunities to more sales last increased markets opportunities and opportunities focus, success. is the selling bringing in portals the involved mini what we
the forward we team. We look So her to contributions. welcome to her
look in believe year positioned with our XXXX. ahead we're for participation uniquely offerings, that fiscal is of infrastructure market to Now We full and vastly we growth expanded solution a underserved. believe let's line in XXXX
online as are and proud success in pleased with more and role offering medication disposal. the reasonable for terms. and look an our our and be training contract We the service, ultimate positive to from route-based tools, on company customer growth of continue alternative the responsiveness, response forward provider user leadership focusing cost-effective We customer to convenient
this Day. for remind prevent turn it over a everyone, you to near opioid treatment. area want a Now abuse or including to quick Diana, great I substances any is in opioid a Diana. DEA will help all raiding We to your find site take could financials is medications DEA's prescription who off the collection locator. before It detail, proper by medicine you the With visiting minute crisis turn the cabinet I'll a Back XX can collection controlled expired and opportunity National the of over expired more or Saturday, by visit collection the drugs Take your call drop to to address site that, I site Drug to unused in or unused just April